Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 204

1.

Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.

Bagó JR, Okolie O, Dumitru R, Ewend MG, Parker JS, Werff RV, Underhill TM, Schmid RS, Miller CR, Hingtgen SD.

Sci Transl Med. 2017 Feb 1;9(375). pii: eaah6510. doi: 10.1126/scitranslmed.aah6510.

PMID:
28148846
2.

Planning horizon affects prophylactic decision-making and epidemic dynamics.

Nardin LG, Miller CR, Ridenhour BJ, Krone SM, Joyce P, Baumgaertner BO.

PeerJ. 2016 Nov 8;4:e2678.

3.

Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?

Miller CR, Chappell NP, Sledge C, Leath CA 3rd, Phippen NT, Havrilesky LJ, Barnett JC.

Gynecol Oncol. 2017 Jan;144(1):125-129. doi: 10.1016/j.ygyno.2016.10.038.

PMID:
27816248
4.

Comparative Evaluation of Potentially Radiolucent Projectile Components by Radiographs and Computed Tomography.

Miller CR, Haag M, Gerrard C, Hatch GM, Elifritz J, Simmons MC, Lathrop S, Nolte KB.

J Forensic Sci. 2016 Nov;61(6):1563-1570. doi: 10.1111/1556-4029.13225.

PMID:
27787896
5.

Predicting the need for nonstandard tracheostomy tubes in critically ill patients.

Pandian V, Hutchinson CT, Schiavi AJ, Feller-Kopman DJ, Haut ER, Parsons NA, Lin JS, Gorbatkin C, Angamuthu PG, Miller CR, Mirski MA, Bhatti NI, Yarmus LB.

J Crit Care. 2017 Feb;37:173-178. doi: 10.1016/j.jcrc.2016.05.025.

PMID:
27756050
6.

Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.

Blount RJ, Tran MC, Everett CK, Cattamanchi A, Metcalfe JZ, Connor D, Miller CR, Grinsdale J, Higashi J, Nahid P.

BMC Public Health. 2016 Aug 25;16(1):875. doi: 10.1186/s12889-016-3519-6.

7.

Love the one you're with: replicate viral adaptations converge on the same phenotypic change.

Miller CR, Nagel AC, Scott L, Settles M, Joyce P, Wichman HA.

PeerJ. 2016 Jul 19;4:e2227. doi: 10.7717/peerj.2227.

8.

BRAF Mutations Open Doors for N-Ethyl-N-Nitrosourea-Induced Gliomagenesis.

McNeill RS, Irvin DM, Miller CR.

Am J Pathol. 2016 Oct;186(10):2551-4. doi: 10.1016/j.ajpath.2016.07.005.

PMID:
27543966
9.

New Perspectives on Ebola Virus Evolution.

Brown CJ, Quates CJ, Mirabzadeh CA, Miller CR, Wichman HA, Miura TA, Ytreberg FM.

PLoS One. 2016 Aug 1;11(8):e0160410. doi: 10.1371/journal.pone.0160410.

10.

Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model.

Okolie O, Bago JR, Schmid RS, Irvin DM, Bash RE, Miller CR, Hingtgen SD.

Neuro Oncol. 2016 Dec;18(12):1622-1633.

PMID:
27298311
11.

Is FDA-Approved Bevacizumab Cost-Effective When Included in the Treatment of Platinum-Resistant Recurrent Ovarian Cancer?

Chappell NP, Miller CR, Fielden AD, Barnett JC.

J Oncol Pract. 2016 Jul;12(7):e775-83. doi: 10.1200/JOP.2015.010470.

PMID:
27246689
12.

Obituary: Paul Joyce (1958-2016).

Miller CR, Wichman HA.

Biol Lett. 2016 May;12(5). pii: 20160396. doi: 10.1098/rsbl.2016.0396. No abstract available.

PMID:
27220862
13.

Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients.

LeBlanc AK, Mazcko C, Brown DE, Koehler JW, Miller AD, Miller CR, Bentley RT, Packer RA, Breen M, Boudreau CE, Levine JM, Simpson RM, Halsey C, Kisseberth W, Rossmeisl JH Jr, Dickinson PJ, Fan TM, Corps K, Aldape K, Puduvalli V, Pluhar GE, Gilbert MR.

Neuro Oncol. 2016 Sep;18(9):1209-18. doi: 10.1093/neuonc/now051. Review.

PMID:
27179361
14.

Initiating a watch list for Ebola virus antibody escape mutations.

Miller CR, Johnson EL, Burke AZ, Martin KP, Miura TA, Wichman HA, Brown CJ, Ytreberg FM.

PeerJ. 2016 Feb 16;4:e1674. doi: 10.7717/peerj.1674.

15.

Genetically Determined Variation in Lysis Time Variance in the Bacteriophage φX174.

Baker CW, Miller CR, Thaweethai T, Yuan J, Baker MH, Joyce P, Weinreich DM.

G3 (Bethesda). 2016 Apr 7;6(4):939-55. doi: 10.1534/g3.115.024075.

16.

Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma.

Bagó JR, Alfonso-Pecchio A, Okolie O, Dumitru R, Rinkenbaugh A, Baldwin AS, Miller CR, Magness ST, Hingtgen SD.

Nat Commun. 2016 Feb 2;7:10593. doi: 10.1038/ncomms10593.

17.

Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide.

Schmid RS, Simon JM, Vitucci M, McNeill RS, Bash RE, Werneke AM, Huey L, White KK, Ewend MG, Wu J, Miller CR.

Neuro Oncol. 2016 Jul;18(7):962-73. doi: 10.1093/neuonc/nov321.

PMID:
26826202
18.

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.

Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA, Morozova O, Newton Y, Radenbaugh A, Pagnotta SM, Anjum S, Wang J, Manyam G, Zoppoli P, Ling S, Rao AA, Grifford M, Cherniack AD, Zhang H, Poisson L, Carlotti CG Jr, Tirapelli DP, Rao A, Mikkelsen T, Lau CC, Yung WK, Rabadan R, Huse J, Brat DJ, Lehman NL, Barnholtz-Sloan JS, Zheng S, Hess K, Rao G, Meyerson M, Beroukhim R, Cooper L, Akbani R, Wrensch M, Haussler D, Aldape KD, Laird PW, Gutmann DH; TCGA Research Network., Noushmehr H, Iavarone A, Verhaak RG.

Cell. 2016 Jan 28;164(3):550-63. doi: 10.1016/j.cell.2015.12.028.

19.

Intrinsic Astrocyte Heterogeneity Influences Tumor Growth in Glioma Mouse Models.

Irvin DM, McNeill RS, Bash RE, Miller CR.

Brain Pathol. 2017 Jan;27(1):36-50. doi: 10.1111/bpa.12348.

PMID:
26762242
20.

Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium.

Allott EH, Cohen SM, Geradts J, Sun X, Khoury T, Bshara W, Zirpoli GR, Miller CR, Hwang H, Thorne LB, O'Connor S, Tse CK, Bell MB, Hu Z, Li Y, Kirk EL, Bethea TN, Perou CM, Palmer JR, Ambrosone CB, Olshan AF, Troester MA.

Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):470-8. doi: 10.1158/1055-9965.EPI-15-0874.

PMID:
26711328
Items per page

Supplemental Content

Loading ...
Support Center